LDHC and cancer: Since we found that aberrant expression of LDHC in tumor cells impacts T cell activity (Fig. 2C-D) and dysregulates the secretion of tumor-derived pro-inflammatory molecules (Fig. 3A-B), we sought to assess the effects of LDHC silencing on cytokine levels in cancer cell-PBL co-culture models.